Relapse and survival in early-stage ovarian cancer

Relapse and survival in early-stage ovarian cancer. [Arch Gynecol Obstet. 2008] - PubMed Result

CONCLUSION:

Patients with early ovarian cancer stage pT1c and pT2a or low grade tumor have to be

monitored closely in oncologic follow-up as they bare a significant risk for disease recurrence.

Ascites at primary diagnosis, pT1c or pT2a tumor stage or recurrent disease are associated

with a poor survival even in early ovarian cancer.